Acadia Healthcare (ACHC) Tops Q2 EPS by 5c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Acadia Healthcare (ACHC) PT Raised to $90 at UBS on Emerging Substance Abuse Opportunity in the UK
August 6, 2015 8:17 AM EDTUBS analyst A.J. Rice reiterated a Buy rating and raised his price target on Acadia Healthcare (NASDAQ: ACHC) to $90.00 (from $85.00) following Q2 results as they see emerging substance abuse opportunity in the UK.
Rice commented, "ACHC announced the acquisition of a 15-bed... More
